calca-protein--human and Weight-Loss

calca-protein--human has been researched along with Weight-Loss* in 2 studies

Other Studies

2 other study(ies) available for calca-protein--human and Weight-Loss

ArticleYear
Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool.
    Critical care (London, England), 2011, Volume: 15, Issue:6

    To develop a scoring method for quantifying nutrition risk in the intensive care unit (ICU).. A prospective, observational study of patients expected to stay > 24 hours. We collected data for key variables considered for inclusion in the score which included: age, baseline APACHE II, baseline SOFA score, number of comorbidities, days from hospital admission to ICU admission, Body Mass Index (BMI) < 20, estimated % oral intake in the week prior, weight loss in the last 3 months and serum interleukin-6 (IL-6), procalcitonin (PCT), and C-reactive protein (CRP) levels. Approximate quintiles of each variable were assigned points based on the strength of their association with 28 day mortality.. A total of 597 patients were enrolled in this study. Based on the statistical significance in the multivariable model, the final score used all candidate variables except BMI, CRP, PCT, estimated percentage oral intake and weight loss. As the score increased, so did mortality rate and duration of mechanical ventilation. Logistic regression demonstrated that nutritional adequacy modifies the association between the score and 28 day mortality (p = 0.01).. This scoring algorithm may be helpful in identifying critically ill patients most likely to benefit from aggressive nutrition therapy.

    Topics: Aged; APACHE; Body Mass Index; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Chi-Square Distribution; Critical Illness; Eating; Female; Humans; Interleukin-6; Length of Stay; Logistic Models; Male; Middle Aged; Nutrition Assessment; Nutrition Therapy; Nutritional Status; Prospective Studies; Protein Precursors; Risk Assessment; Statistics, Nonparametric; Weight Loss

2011
C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.
    World journal of gastroenterology, 2004, Apr-15, Volume: 10, Issue:8

    The current study was to determine the serum/plasma levels of VEGF, IL-6, malondialdehyde (MDA), nitric oxide (NO), PCT and CRP in gastric carcinoma and correlation with the stages of the disease and accompanying infection.. We examined the levels of serum VEGF, IL-6, PCT, CRP and plasma MDA, NO in 42 preoperative gastric cancer patients and 23 healthy subjects. There were infection anamneses that had no definite origin in 19 cancer patients.. The VEGF levels (mean+/-SD; pg/mL) were 478.05+/-178.29 and 473.85+/-131.24 in gastric cancer patients with and without infection, respectively, and these values were not significantly different (P>0.05). The levels of VEGF, CRP, PCT, IL-6, MDA and NO in cancer patients were significantly higher than those in healthy controls and the levels of CRP, PCT, IL-6, MDA and NO were statistically increased in infection group when compared with non-infection group (P<0.001).. Although serum VEGF concentrations were increased in gastric cancer, this increase might not be related to infection. CRP, PCT, IL-6, MDA and NO have obvious drawbacks in the diagnosis of infections in cancer patients. These markers may not help to identify infections in the primary evaluation of cancer patients and hence to avoid unnecessary antibiotic treatments as well as hospitalization. According to the results of this study, IL-6, MDA, NO and especially VEGF can be used as useful parameters to diagnose and grade gastric cancer.

    Topics: Abdominal Pain; Aged; Biomarkers; Biomarkers, Tumor; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Female; Helicobacter Infections; Humans; Interleukin-6; Male; Malnutrition; Malondialdehyde; Middle Aged; Neoplasm Staging; Nitric Oxide; Oxidative Stress; Protein Precursors; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Vomiting; Weight Loss

2004